P53 Expression and Malignancy Risk in GISTs
Author Information
Author(s): Pauser Ursula, Schmedt auf der Günne Nina, Klöppel Günter, Merz Hartmut, Feller Alfred C
Primary Institution: Department of Pathology, University of Lübeck, Germany
Hypothesis
The study aims to evaluate cell cycle regulators as potential prognostic markers in gastrointestinal stromal tumors (GISTs).
Conclusion
P53 is a significant marker for predicting the risk of malignancy in GISTs and is correlated with epithelioid differentiation.
Supporting Evidence
- P53 expression was significantly correlated with high risk criteria towards malignancy.
- P53 label correlated significantly with tumor size, mitotic rate, nuclear atypia, and proliferative activity.
- BCL-2 and Cyclin D1 expression did not correlate with prognostic indicators.
Takeaway
This study found that a protein called P53 can help doctors figure out how dangerous certain tumors in the stomach and intestines are.
Methodology
The study analyzed 104 KIT positive GISTs using immunoassays on various proteins and correlated the results with tumor characteristics.
Potential Biases
Potential bias due to the retrospective nature of the study and reliance on existing clinical data.
Limitations
The study is retrospective and relies on previously collected specimens, which may limit the generalizability of the findings.
Participant Demographics
The study included 59 female and 45 male patients aged 24 to 90 years, with a mean age of 62.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website